The situation
Every deal thesis quietly assumes a leadership team: founders who can become operators, clinical leaders who can become executives, a bench that can double with the business. Those assumptions are rarely tested until they fail — and a failed operator costs more than a failed hire. It costs a year of the hold. The fix is not another search. It is evidence about the leaders already in place, and development that starts while there is still time for it to matter.
The work, by deal cycle
Pre-close — talent diligence
A structured read on the leaders the thesis depends on, before the deal signs: who can scale, who is a flight or failure risk, where the gaps sit. Evidence for the investment committee, not impressions from the management meeting.
First 100 days — assessment while the chart is fluid
Assessment of the senior team while roles are still being set. Sponsors and CEOs get a written, evidence-based read before the org chart hardens around the wrong people.
Hold period — coaching and leadership labs
Post-acquisition coaching for founders, clinical leaders, and operators: aligning on priorities, having direct conversations earlier, delegating beyond the founder or clinical leader, executing against the thesis. For companies building a bench, a 12-month leadership lab: a cohort of senior leaders, each with coaching and a confidential 360, working in small action-learning teams on live operating problems — producing operating tools the company keeps.
Exit readiness — a bench the buyer can see
Succession depth and leadership evidence that survives diligence. The next owner will assess your leaders; better that you have the evidence first.
When the answer is a hire
Assessment sometimes concludes that the gap cannot be developed closed in time. Then the gap is filled under a separate roof: Bench Strength does not conduct searches — the search is an August Leadership engagement, run by August's search consultants across the Americas, Europe, Asia-Pacific, the Middle East, and Africa, with finalists assessed to the same standard as the leaders already in place. Diligence on the way in, development through the hold, search when the bench runs out.
Proof
Carrie coaches leaders across healthcare companies backed by leading private equity sponsors, in the years right after acquisition. Our current lab is developing 15 leaders inside a PE-owned healthcare operator that is roughly doubling its footprint — growth that has to be led, not just staffed. Sponsors see development priorities and progress; the substance of individual coaching stays private, agreed up front.
Your principals on this work
Jeffrey Cohn leads sponsor and board-level conversations. Dr. Carrie Muchow leads assessment and coaching. Both are personally in the room — no junior bench, no handoff after the sale. Behind them, August Leadership's global partnership.
AboutIs this right for your company?
- Is growth outrunning the leadership bench?
- Is the founder or clinical leader still the answer to every hard question?
- Did the thesis assume leaders nobody has actually assessed?
If so, the assessment is cheaper than the replacement.
Start with one confidential conversation about one live transition.
Start a conversation